I-MED Research Institute (IMRI)
Our industry-leading research institute is dedicated to investigating new and innovative practices aimed at providing patients with better diagnostic and treatment options. We champion the continuous betterment of patient care that rigorous scientific research enables.
I-MED Research Institute (IMRI)
Our industry-leading research institute is dedicated to investigating new and innovative practices aimed at providing patients with better diagnostic and treatment options. We champion the continuous betterment of patient care that rigorous scientific research enables.
Introduction
We aim to pioneer medical research within the radiology profession, leading the industry in new and innovative practices. IMRI consolidates research performed across the I-MED Radiology Network including investigator-initiated research projects and trials; collaborations with external partners such as universities and research organisations; and imaging/reporting services for external projects.
The concept of IMRI began with the initial work of our accomplished research team at The Wesley Hospital in Queensland and now extends to studies and projects in progress across the country.
Benefits of IMRI-led research
- Research findings may lead to the adaptation of new and innovative practices into standard care, the learnings from these practices will benefit our patients.
- Through evidence-based and research-informed improvements in practices, I‑MED is able to provide innovative treatments and interventions for patients, continuously improving the safety and efficacy of radiology services.
- Improvement of standard care practices gained through our research work can lead to the extension of newly developed evidence-based practices nationally to all I-MED clinics.
Recent Published Articles
- The 'Prostate Embolisation AS first-line therapY compAred to meDication in treatment naïVe men with prostAte eNlargement, a randomised ControllEd trial' (P-EASY ADVANCE): a randomised controlled trial of prostate embolisation vs medication for BPH - PubMed
- Treatment of pulmonary artery pseudoaneurysms and stenosis with balloon‐expandable stents
- Lu177-PSMA therapy for men with advanced prostate cancer: 18 months survival analysis in a single Australian tertiary institution - PubMed
- Silicosis in artificial stone workers: Spectrum of radiological high-resolution CT chest findings - PubMed
- Prostate artery Embolisation Assessment of Safety and feasibilitY (P-EASY): a potential alternative to long-term medical therapy for benign prostate hyperplasia - PubMed
- Initial multicentre experience of 68 gallium-PSMA PET/CT guided robot-assisted salvage lymphadenectomy: acceptable safety profile but oncological benefit appears limited - PubMed
click-hereInterested in joining us?
Are you interested in being involved in research with us? Send an email to research@i-med.com.au.